Mesoblast | MSB - Betriebsaufwand

Aktienkurs
2.06
Täglich Wechseln
0.01 0.49%
Monatlich
-12.34%
Jährlich
-7.62%
Q1 Prognose
2.02




Betriebsaufwand Veränderung Datum
Avita Medical AUD 28.02M 1.55M 2025-12
Clinuvel Pharmaceuticals AUD 23.42M 6.49M 2025-12
Cochlear AUD 914.9M 454.8M 2025-12
CSL USD 5.7B 2.82B 2025-12
Pacific Edge NZD 25.34M 2.03M 2025-12
Paradigm Biopharmaceuticals AUD 21.85M 13.36M 2025-12
PYC Therapeutics AUD 33.63M 14.33M 2025-12
Ramsay Health Care AUD 8.8B 83.5M 2025-12
Sonic Healthcare AUD 4.23B 2.14B 2024-12
Starpharma Holdings AUD 11.7M 7.69M 2025-12
Telix Pharmaceuticals AUD 405.4M 26.29M 2025-12